Invirsa, Inc. — Form D/A
Invirsa, Inc. of COLUMBUS, OH, a company, filed a Form D amendment with the SEC on 2025-08-08. The offering totals $2.9M, of which $2.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-08-08
- Form: D/A
- Accession: 0001836108-25-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.9M
- Amount sold: $2.9M
- Investors: 14
- Date of first sale: 2025-07-22
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-553807
Issuer
- Name: Invirsa, Inc.
- CIK: 0001836108
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 1275 KINNEAR ROAD, COLUMBUS, OH, 43212
- Phone: 614-715-1860
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Wayne Embree | Director | Columbus, OH |
| Robert Shalwitz | Director | Columbus, OH |
| Faith Voinovich | Director | Columbus, OH |
| Tim Willis | Director | Columbus, OH |
| Robert Shalwitz | Executive Officer | Columbus, OH |
| Rachael Wingo | Executive Officer | Columbus, OH |
| Samuel Lee | Director | San Juan, PR |
| Bethany George | Director | Columbus, OH |
| Michael Venerable | Director | Cleveland, OH |
Other filings by this issuer (4)
More